"Using a flash of light, scientists have inactivated and then reactivated a memory in genetically engineered rats. The study, supported by the National Institutes of Health, is the first cause-and-effect evidence that strengthened connections betw"...
NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA).
PBA occurs secondary to a variety of otherwise unrelated neurologic conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the underlying emotional state. PBA is a specific condition, distinct from other types of emotional lability that may occur in patients with neurological disease or injury.
DOSAGE AND ADMINISTRATION
The recommended starting dose of NUEDEXTA is one capsule daily by mouth for the initial seven days of therapy. On the eighth day of therapy and thereafter, the daily dose should be a total of two capsules a day, given as one capsule every 12 hours.
The need for continued treatment should be reassessed periodically, as spontaneous improvement of PBA occurs in some patients.
Dosage Forms And Strengths
NUEDEXTA capsules contain 20 mg dextromethorphan hydrobromide and 10 mg quinidine sulfate in a brick red gelatin capsule with “DMQ / 20-10” printed in white ink on the capsule.
Storage And Handling
NUEDEXTA is supplied as brick red gelatin capsules imprinted with “DMQ / 20-10”. NUEDEXTA is supplied in the following package configuration:
|Package Configuration||Capsule Strength (mg)||NDC Code|
|Bottles of 60 (30 day supply)||dextromethorphan 20 mg/ quinidine 10 mg||64597-301-60|
Store NUEDEXTA capsules at controlled room temperature, 25°C (77°F); excursions permitted to 15° 30 °C (59° -86°F) [See USP Controlled Room Temperature].
Marketed by: Avanir Pharmaceuticals, Inc. Aliso Viejo, CA 92656. 1-949-389-6700. Revised January 2015
Last reviewed on RxList: 1/30/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Nuedexta Capsules Information
- Nuedexta Capsules Drug Interactions Center: dextromethorphan-quinidine oral
- Nuedexta Capsules Side Effects Center
- Nuedexta Capsules in detail including Side Effects and Drug Images
- Nuedexta Capsules Overview including Precautions
- Nuedexta Capsules FDA Approved Prescribing Information including Dosage
Nuedexta Capsules - User Reviews
Nuedexta Capsules User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.